Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

NCT05561985 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2025-06-08

No results posted yet for this study

Summary

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Conditions

  • STAT1 Gain-of-Function Disease

Interventions

DRUG

Itacitinib

Sponsors & Collaborators

Principal Investigators

  • Lisa Forbes Satter, MD · Baylor College of Medicine - Texas Children's Hospital

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05561985 on ClinicalTrials.gov